New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs

Researchers have developed a new protease inhibitor effective against mutating strains of the human AIDS virus that are resistant to current drugs, according to a just-released report in the peer-reviewed Journal of the American Chemical Society.

The paper will be published on the web on Feb. 4 and will be in the journal's Feb. 17 print edition. The American Chemical Society is the world's largest scientific society.

Most AIDS drugs disable the human immunodeficiency virus (HIV) by latching onto an enzyme, such as a protease, that the virus needs to multiply. However, HIV quickly mutates and becomes resistant to individual inhibitors within weeks.

The most successful treatment to date tries to overwhelm HIV with two or three of these drugs simultaneously in a so-called "combination therapy," but even this approach eventually loses effectiveness.

Researchers at The Scripps Research Institute in La Jolla, Calif. think they now know how HIV adapts so readily to the current treatments. Over time, HIV proteases apparently change structure so that the inhibitors can no longer bind tightly. "We have studied the mutation pattern of HIV protease from patients who take the existing drugs and found that the enzyme often rejects the drug by reducing the size of the drug binding site," says Scripps chemist Chi-Huey Wong, Ph.D.

The scientists then looked at the corresponding binding site on current HIV protease inhibitors and found that most of them have large chemical structures that interact with the constricted areas in drug-resistant proteases. So they redesigned the drugs, giving them a smaller chemical group at the critical binding site. In laboratory tests, the new class of inhibitors was effective against both HIV protease and its drug-resistant mutants. "More importantly," adds Wong, "no resistant mutants were detected in cell culture after one year the new drug may last longer as the chance for development of drug resistance is lower

Contact: Nancy Blount
American Chemical Society

Page: 1 2

Related medicine news :

1. Protease inhibitor could help prevent alzheimers
2. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
3. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
4. Answers To Access, Adherence And Tolerance Of Protease Inhibitors
5. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors
6. Inhibitors prevent aggresome formation associated with some forms of ALS
7. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw
8. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
9. ACE-Inhibitors Score High In Reducing Heart Attack Deaths
10. Could skin cells become brain cells?
11. Could autoantibodies predict future disease in healthy people?

Post Your Comments:

(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... With Valentine’s ... sexually transmitted disease (STD) testing service, is sharing 7 tips to ensure ‘Safe Sex’: ... especially if you’re going to engage in safe sex. Having clear, open, and honest ...
(Date:2/13/2019)... , ... February 13, 2019 , ... Infertility is an issue for 1 in 6 ... A startling 2017 study outlining the sharp decline in male sperm count over the last ... , garnering worldwide attention and causing panic that we are in the midst of a ...
(Date:2/13/2019)... Ill. (PRWEB) , ... February 13, 2019 , ... Surgery ... significantly effective and safe treatment for obstructive sleep apnea (OSA), resulting in benefits that ... cardiovascular risk, according to a new study. , MMA should be regarded as the ...
(Date:2/12/2019)... ... February 12, 2019 , ... ... consulting organization, devoted to helping hospital leaders, staff, and physicians achieve excellence, ... . The website now features a streamlined design, improved functionality, and robust ...
(Date:2/12/2019)... ... February 12, 2019 , ... Surgical Theater is ... satisfaction, improve patient retention, and reduce patient outmigration for attendees of the Healthcare ... provides Surgical Theater with a great venue to highlight the value of patient ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... 2019 , ... Sensible Surrogacy today has launched a new ... couples who are unable to afford the staggering cost of surrogacy in the ... America or Eastern Europe for legal and secure surrogacy procedures. However North American ...
(Date:2/13/2019)... ... February 13, 2019 , ... Wound Care centers across the ... EHR software as an app inside their hospital’s EHR, substantially improving continuity of ... (electronic health record) pioneer, will soon launch its award-winning software as an “app” ...
(Date:2/13/2019)... ... February 13, 2019 , ... Abu Dhabi ... Private Partnership (PPP) between the Department of Health-Abu Dhabi (DoH) and Injazat Data ... Information Exchange system (HIE), a centralized platform to streamline healthcare connectivity for the ...
Breaking Medicine Technology:
Cached News: